GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:2000054
|
BP
|
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification
|
Any process that stops, prevents, or reduces the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.
|
SFRP1,
SOST
|
GO:2000055
|
BP
|
positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification
|
Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.
|
LRP6
|
GO:2000057
|
BP
|
negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis
|
Any process that stops, prevents, or reduces the frequency, rate or extent of Wnt signaling pathway involved in digestive tract morphogenesis.
|
SFRP5
|
GO:2000059
|
BP
|
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process
|
Any process that stops, prevents, or reduces the frequency, rate or extent of protein ubiquitination involved in ubiquitin-dependent protein catabolic process.
|
PSEN1,
HFE,
PDCL3,
TRIM39,
SUFU
|
GO:2000060
|
BP
|
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process
|
Any process that activates or increases the frequency, rate or extent of protein ubiquitination involved in ubiquitin-dependent protein catabolic process.
|
AXIN1,
CLU,
PTEN,
PTK2,
FBXO22
|
GO:2000065
|
BP
|
negative regulation of cortisol biosynthetic process
|
Any process that stops, prevents, or reduces the frequency, rate or extent of cortisol biosynthetic process.
|
BMP2,
DKK3
|
GO:2000074
|
BP
|
regulation of type B pancreatic cell development
|
Any process that modulates the frequency, rate or extent of pancreatic B cell development.
|
ARNTL,
RHEB
|
GO:2000077
|
BP
|
negative regulation of type B pancreatic cell development
|
Any process that stops, prevents, or reduces the frequency, rate or extent of pancreatic B cell development.
|
GSK3B
|
GO:2000078
|
BP
|
positive regulation of type B pancreatic cell development
|
Any process that activates or increases the frequency, rate or extent of pancreatic B cell development.
|
BAD
|
GO:2000080
|
BP
|
negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
|
SFRP1
|
GO:2000095
|
BP
|
regulation of Wnt signaling pathway, planar cell polarity pathway
|
Any process that modulates the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
|
NPHP3,
MKS1,
DACT1
|
GO:2000096
|
BP
|
positive regulation of Wnt signaling pathway, planar cell polarity pathway
|
Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
|
DAB2,
RSPO3
|
GO:2000097
|
BP
|
regulation of smooth muscle cell-matrix adhesion
|
Any process that modulates the frequency, rate or extent of smooth muscle cell-matrix adhesion.
|
PLAU
|
GO:2000098
|
BP
|
negative regulation of smooth muscle cell-matrix adhesion
|
Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell-matrix adhesion.
|
APOD,
SERPINE1
|
GO:2000105
|
BP
|
positive regulation of DNA-dependent DNA replication
|
Any process that activates or increases the frequency, rate or extent of DNA-dependent DNA replication.
|
BMP4,
BMP6
|
GO:2000107
|
BP
|
negative regulation of leukocyte apoptotic process
|
Any process that stops, prevents, or reduces the frequency, rate or extent of leukocyte apoptotic process.
|
HCLS1,
CXCL12,
MERTK
|
GO:2000108
|
BP
|
positive regulation of leukocyte apoptotic process
|
Any process that activates or increases the frequency, rate or extent of leukocyte apoptotic process.
|
NR4A3
|
GO:2000109
|
BP
|
regulation of macrophage apoptotic process
|
Any process that modulates the frequency, rate or extent of macrophage apoptotic process.
|
TCP1
|
GO:2000110
|
BP
|
negative regulation of macrophage apoptotic process
|
Any process that stops, prevents, or reduces the frequency, rate or extent of macrophage apoptotic process.
|
CCL5,
VIMP
|
GO:2000111
|
BP
|
positive regulation of macrophage apoptotic process
|
Any process that activates or increases the frequency, rate or extent of macrophage apoptotic process.
|
MEF2C
|
GO:2000114
|
BP
|
regulation of establishment of cell polarity
|
Any process that modulates the frequency, rate or extent of establishment of cell polarity.
|
KRIT1,
ROCK2,
CDH5,
RACK1,
KANK1,
RICTOR,
RUFY3,
KIF20B
|
GO:2000116
|
BP
|
regulation of cysteine-type endopeptidase activity
|
Any process that modulates the frequency, rate or extent of cysteine-type endopeptidase activity.
|
PSMB9,
BIRC3
|
GO:2000117
|
BP
|
negative regulation of cysteine-type endopeptidase activity
|
Any process that stops, prevents, or reduces the frequency, rate or extent of cysteine-type endopeptidase activity.
|
CST3,
CST2,
MT3,
IFI16
|
GO:2000119
|
BP
|
negative regulation of sodium-dependent phosphate transport
|
Any process that stops, prevents, or reduces the frequency, rate or extent of sodium-dependent phosphate transport.
|
SFRP4
|
GO:2000121
|
BP
|
regulation of removal of superoxide radicals
|
Any process that modulates the frequency, rate or extent of removal of superoxide radicals.
|
DHFR,
CD36
|
GO:2000124
|
BP
|
regulation of endocannabinoid signaling pathway
|
Any process that modulates the frequency, rate or extent of endocannabinoid signaling pathway.
|
MGLL,
ABHD6
|
GO:2000134
|
BP
|
negative regulation of G1/S transition of mitotic cell cycle
|
Any cell cycle regulatory process that prevents the commitment of a cell from G1 to S phase of the mitotic cell cycle.
|
CTDSP2,
CTDSPL,
RB1,
BCL2,
CDKN1A,
CDKN2B,
SMARCA4,
PTEN,
PKD2,
FHL1,
EZH2,
KANK2,
JADE1,
ZNF655,
CTDSP1,
BRD7,
DACT1
|
GO:2000137
|
BP
|
negative regulation of cell proliferation involved in heart morphogenesis
|
Any process that stops, prevents, or reduces the frequency, rate or extent of cell proliferation involved in heart morphogenesis.
|
BMP4
|
GO:2000138
|
BP
|
positive regulation of cell proliferation involved in heart morphogenesis
|
Any process that activates or increases the frequency, rate or extent of cell proliferation involved in heart morphogenesis.
|
BMP10,
SOX9
|
GO:2000142
|
BP
|
regulation of DNA-templated transcription, initiation
|
Any process that modulates the frequency, rate or extent of DNA-templated transcription initiation.
|
RRN3
|
GO:2000143
|
BP
|
negative regulation of DNA-templated transcription, initiation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of DNA-templated transcription initiation.
|
THRA
|
GO:2000144
|
BP
|
positive regulation of DNA-templated transcription, initiation
|
Any process that activates or increases the frequency, rate or extent of DNA-templated transcription initiation.
|
MITF,
JUN,
FOSL1,
CTNNB1,
TWIST1,
SETX,
BCLAF1
|
GO:2000145
|
BP
|
regulation of cell motility
|
Any process that modulates the frequency, rate or extent of cell motility.
|
EREG,
DAPK3,
ROCK2,
EGFR,
RAF1,
ERBB2,
ERBB3,
BTC,
ABL2,
CD81,
RHOA,
CDK6,
NRG1,
ERBB4,
PKN1,
PKN2,
ARHGAP18,
HBEGF,
SSX2IP
|
GO:2000146
|
BP
|
negative regulation of cell motility
|
Any process that stops, prevents, or reduces the frequency, rate or extent of cell motility.
|
SPINT2,
FBLN1,
CTNNA1,
SPOCK3
|
GO:2000147
|
BP
|
positive regulation of cell motility
|
Any process that activates or increases the frequency, rate or extent of cell motility.
|
CSF1R,
EPCAM,
AKT2,
TWIST1,
SPOCK2,
PHPT1
|
GO:2000156
|
BP
|
regulation of retrograde vesicle-mediated transport, Golgi to ER
|
Any process that modulates the frequency, rate or extent of retrograde vesicle-mediated transport, Golgi to ER.
|
BET1L
|
GO:2000158
|
BP
|
positive regulation of ubiquitin-specific protease activity
|
Any process that activates or increases the frequency, rate or extent of ubiquitin-specific protease (deubiquitinase) activity.
|
VCP,
TANK
|
GO:2000167
|
BP
|
regulation of planar cell polarity pathway involved in neural tube closure
|
Any process that modulates the frequency, rate or extent of planar cell polarity pathway involved in neural tube closure.
|
NPHP3
|
GO:2000170
|
BP
|
positive regulation of peptidyl-cysteine S-nitrosylation
|
Any process that activates or increases the frequency, rate or extent of peptidyl-cysteine S-nitrosylation.
|
ACE
|
GO:2000171
|
BP
|
negative regulation of dendrite development
|
Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite development.
|
CARM1
|
GO:2000172
|
BP
|
regulation of branching morphogenesis of a nerve
|
Any process that modulates the frequency, rate or extent of branching morphogenesis of a nerve.
|
SHOX2,
RTN4
|
GO:2000177
|
BP
|
regulation of neural precursor cell proliferation
|
Any process that modulates the frequency, rate or extent of neural precursor cell proliferation.
|
FOXO3,
NF2,
FOXO1,
SHCBP1,
PTBP2
|
GO:2000178
|
BP
|
negative regulation of neural precursor cell proliferation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of neural precursor cell proliferation.
|
SPINT2,
BTG2,
ID2,
ILK,
RAPGEF1
|
GO:2000179
|
BP
|
positive regulation of neural precursor cell proliferation
|
Any process that activates or increases the frequency, rate or extent of neural precursor cell proliferation.
|
KDM1A,
NES,
ASCL1,
GNG5,
INSM1,
KIAA1524,
PROX1,
DLL4,
ADGRG1
|
GO:2000182
|
BP
|
regulation of progesterone biosynthetic process
|
Any process that modulates the frequency, rate or extent of progesterone biosynthetic process.
|
EGR1
|
GO:2000184
|
BP
|
positive regulation of progesterone biosynthetic process
|
Any process that activates or increases the frequency, rate or extent of progesterone biosynthetic process.
|
PPARGC1A
|
GO:2000188
|
BP
|
regulation of cholesterol homeostasis
|
Any process that modulates the frequency, rate or extent of cholesterol homeostasis.
|
LDLR,
NR1D1,
RORA,
NR1H2,
SREBF2,
NR1H3,
NR1H4
|
GO:2000189
|
BP
|
positive regulation of cholesterol homeostasis
|
Any process that activates or increases the frequency, rate or extent of cholesterol homeostasis.
|
NPC1,
NR1H3
|
GO:2000191
|
BP
|
regulation of fatty acid transport
|
Any process that modulates the frequency, rate or extent of fatty acid transport.
|
NCOR1,
REPIN1
|
GO:2000194
|
BP
|
regulation of female gonad development
|
Any process that modulates the frequency, rate or extent of female gonad development.
|
NUPR1,
INSR
|
GO:2000195
|
BP
|
negative regulation of female gonad development
|
Any process that stops, prevents, or reduces the frequency, rate or extent of female gonad development.
|
WT1,
ZFPM2
|
GO:2000210
|
BP
|
positive regulation of anoikis
|
Any process that activates or increases the frequency, rate or extent of anoikis.
|
SIK1,
AES,
MYBBP1A
|
GO:2000213
|
BP
|
positive regulation of glutamate metabolic process
|
Any process that activates or increases the frequency, rate or extent of glutamate metabolic process.
|
NR1H4
|
GO:2000224
|
BP
|
regulation of testosterone biosynthetic process
|
Any process that modulates the frequency, rate or extent of testosterone biosynthetic process.
|
AKR1C3
|
GO:2000227
|
BP
|
negative regulation of pancreatic A cell differentiation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of pancreatic A cell differentiation.
|
HES1
|
GO:2000230
|
BP
|
negative regulation of pancreatic stellate cell proliferation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of pancreatic stellate cell proliferation.
|
PPARG
|
GO:2000233
|
BP
|
negative regulation of rRNA processing
|
Any process that stops, prevents, or reduces the frequency, rate or extent of rRNA processing.
|
SHQ1,
NUDT16
|
GO:2000249
|
BP
|
regulation of actin cytoskeleton reorganization
|
Any process that modulates the frequency, rate or extent of actin cytoskeleton reorganization.
|
RHOD,
SEMA3E,
DAPK3,
TGFB1,
CSF1R,
PDGFRA,
ABL2,
ARHGDIA,
ARHGDIB,
PHPT1,
F11R
|
GO:2000251
|
BP
|
positive regulation of actin cytoskeleton reorganization
|
Any process that activates or increases the frequency, rate or extent of actin cytoskeleton reorganization.
|
HAX1,
HCLS1,
CDK5,
TEK,
BAIAP2L1
|
GO:2000252
|
BP
|
negative regulation of feeding behavior
|
Any process that stops, prevents or reduces the frequency, rate or extent of feeding behavior.
|
INS,
TRH,
MC4R,
NPY2R,
RETN
|
GO:2000253
|
BP
|
positive regulation of feeding behavior
|
Any process that activates or increases the frequency, rate or extent of feeding behavior.
|
AGRP,
NR4A3
|
GO:2000255
|
BP
|
negative regulation of male germ cell proliferation
|
Any process that stops, prevents or reduces the frequency, rate or extent of male germ cell proliferation.
|
PTGDS,
PRDX4
|
GO:2000256
|
BP
|
positive regulation of male germ cell proliferation
|
Any process that activates or increases the frequency, rate or extent of male germ cell proliferation.
|
CIB1
|
GO:2000266
|
BP
|
regulation of blood coagulation, intrinsic pathway
|
Any process that modulates the frequency, rate or extent of blood coagulation, intrinsic pathway.
|
SERPINC1
|
GO:2000269
|
BP
|
regulation of fibroblast apoptotic process
|
Any process that modulates the frequency, rate or extent of fibroblast apoptotic process.
|
IER3IP1
|
GO:2000270
|
BP
|
negative regulation of fibroblast apoptotic process
|
Any process that stops, prevents or reduces the frequency, rate or extent of fibroblast apoptotic process.
|
PIK3CA,
PIK3CG,
GAS6,
SFRP1,
CHD8,
CFDP1
|
GO:2000271
|
BP
|
positive regulation of fibroblast apoptotic process
|
Any process that activates or increases the frequency, rate or extent of fibroblast apoptotic process.
|
BCL2L11,
STK17B,
BTG1,
SFRP1
|
GO:2000272
|
BP
|
negative regulation of receptor activity
|
Any process that stops, prevents or reduces the frequency, rate or extent of receptor activity.
|
HFE,
LYPD1,
PCSK9,
PPARGC1A
|
GO:2000273
|
BP
|
positive regulation of receptor activity
|
Any process that activates or increases the frequency, rate or extent of receptor activity.
|
GREM1,
IGF2,
ANXA2,
ACTN2,
CDK5,
NCOA2,
HFE,
PPARGC1B,
SRA1,
BAZ1B,
MED16
|
GO:2000276
|
BP
|
negative regulation of oxidative phosphorylation uncoupler activity
|
Any process that stops, prevents or reduces the frequency, rate or extent of oxidative phosphorylation uncoupler activity.
|
PPIF,
TWIST1
|
GO:2000278
|
BP
|
regulation of DNA biosynthetic process
|
Any process that modulates the frequency, rate or extent of DNA biosynthetic process.
|
CDKN1A,
SH2B1
|
GO:2000279
|
BP
|
negative regulation of DNA biosynthetic process
|
Any process that stops, prevents or reduces the frequency, rate or extent of DNA biosynthetic process.
|
GJA1,
DUSP1,
BMPR2,
ANKRD1,
RGN,
ADIPOQ,
DACH1
|
GO:2000286
|
BP
|
receptor internalization involved in canonical Wnt signaling pathway
|
A receptor internalization process that contributes to canonical Wnt signaling pathway.
|
RAB5A,
CAV1
|
GO:2000288
|
BP
|
positive regulation of myoblast proliferation
|
Any process that activates or increases the frequency, rate or extent of myoblast proliferation.
|
SOX15,
PPARD,
PITX2,
PAXBP1
|
GO:2000296
|
BP
|
negative regulation of hydrogen peroxide catabolic process
|
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide catabolic process.
|
HP,
MT3
|
GO:2000297
|
BP
|
negative regulation of synapse maturation
|
Any process that stops, prevents or reduces the frequency, rate or extent of synapse maturation.
|
NFATC4
|
GO:2000299
|
BP
|
negative regulation of Rho-dependent protein serine/threonine kinase activity
|
Any process that stops, prevents or reduces the frequency, rate or extent of Rho-dependent protein serine/threonine kinase activity.
|
CHORDC1
|
GO:2000300
|
BP
|
regulation of synaptic vesicle exocytosis
|
Any process that modulates the frequency, rate or extent of synaptic vesicle exocytosis.
|
SYN1,
RAB5A,
RIMS4,
RIMS2
|
GO:2000301
|
BP
|
negative regulation of synaptic vesicle exocytosis
|
Any process that stops, prevents or reduces the frequency, rate or extent of synaptic vesicle exocytosis.
|
RAP1A,
FMR1
|
GO:2000302
|
BP
|
positive regulation of synaptic vesicle exocytosis
|
Any process that activates or increases the frequency, rate or extent of synaptic vesicle exocytosis.
|
NLGN1
|
GO:2000304
|
BP
|
positive regulation of ceramide biosynthetic process
|
Any process that activates or increases the frequency, rate or extent of ceramide biosynthetic process.
|
CYR61,
TNF,
RACK1,
PRKCD,
NSMAF
|
GO:2000309
|
BP
|
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production
|
Any process that activates or increases the frequency, rate or extent of tumor necrosis factor (ligand) superfamily member 11 production.
|
ADAM8
|
GO:2000310
|
BP
|
regulation of N-methyl-D-aspartate selective glutamate receptor activity
|
Any process that modulates the frequency, rate or extent of N-methyl-D-aspartate selective glutamate receptor activity.
|
DAPK1,
DLG4,
MEF2C,
MAPK8IP2,
NLGN1,
PPARGC1A
|
GO:2000311
|
BP
|
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity
|
Any process that modulates the frequency, rate or extent of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity.
|
MEF2C,
MAPK8IP2,
NLGN1,
MINK1,
CACNG8
|
GO:2000312
|
BP
|
regulation of kainate selective glutamate receptor activity
|
Any process that modulates the frequency, rate or extent of kainate selective glutamate receptor activity.
|
KLHL24,
NETO2
|
GO:2000318
|
BP
|
positive regulation of T-helper 17 type immune response
|
Any process that activates or increases the frequency, rate or extent of T-helper 17 type immune response.
|
IL12RB1,
PRKCQ
|
GO:2000320
|
BP
|
negative regulation of T-helper 17 cell differentiation
|
Any process that stops, prevents or reduces the frequency, rate or extent of T-helper 17 cell differentiation.
|
FOXP3
|
GO:2000323
|
BP
|
negative regulation of glucocorticoid receptor signaling pathway
|
Any process that stops, prevents or reduces the frequency, rate or extent of glucocorticoid receptor signaling pathway.
|
ARNTL,
PER1,
PHB,
CRY1
|
GO:2000327
|
BP
|
positive regulation of ligand-dependent nuclear receptor transcription coactivator activity
|
Any process that activates or increases the frequency, rate or extent of ligand-dependent nuclear receptor transcription coactivator activity.
|
CNOT6
|
GO:2000330
|
BP
|
positive regulation of T-helper 17 cell lineage commitment
|
Any process that activates or increases the frequency, rate or extent of T-helper 17 cell lineage commitment.
|
IL12RB1
|
GO:2000334
|
BP
|
positive regulation of blood microparticle formation
|
Any process that activates or increases the frequency, rate or extent of blood microparticle formation.
|
TNF,
CD36
|
GO:2000340
|
BP
|
positive regulation of chemokine (C-X-C motif) ligand 1 production
|
Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production.
|
TIRAP,
TRPV4
|
GO:2000342
|
BP
|
negative regulation of chemokine (C-X-C motif) ligand 2 production
|
Any process that stops, prevents or reduces the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
|
KLF4,
MAP2K5
|
GO:2000343
|
BP
|
positive regulation of chemokine (C-X-C motif) ligand 2 production
|
Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
|
TNF,
CD74,
MIF,
TIRAP,
HDAC1
|
GO:2000344
|
BP
|
positive regulation of acrosome reaction
|
Any process that activates or increases the frequency, rate or extent of the acrosome reaction.
|
ZP3,
PLCB1
|
GO:2000345
|
BP
|
regulation of hepatocyte proliferation
|
Any process that modulates the frequency, rate or extent of hepatocyte proliferation.
|
SULF2
|
GO:2000346
|
BP
|
negative regulation of hepatocyte proliferation
|
Any process that stops, prevents or reduces the frequency, rate or extent of hepatocyte proliferation.
|
CPB2
|
GO:2000347
|
BP
|
positive regulation of hepatocyte proliferation
|
Any process that activates or increases the frequency, rate or extent of hepatocyte proliferation.
|
XBP1,
TNFAIP3
|
GO:2000348
|
BP
|
regulation of CD40 signaling pathway
|
Any process that modulates the frequency, rate or extent of signaling via the CD40 signaling pathway.
|
FANCD2
|
GO:2000349
|
BP
|
negative regulation of CD40 signaling pathway
|
Any process that stops, prevents or reduces the frequency, rate or extent of signaling via the CD40 signaling pathway.
|
TNFAIP3
|